Mast Therapeutics Inc

Available to platforms

Mast Therapeutics Inc. (Ticker: MSTX) was a biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. Its lead product candidate, vepoloxamer, was investigated as a treatment for sickle cell disease and heart failure. In 2017, Mast Therapeutics merged with Savara Inc., a company specializing in therapies for rare respiratory diseases, marking a strategic shift toward advancing treatments for orphan lung conditions.

Mast Therapeutics Inc - MSTX stocks live chart

Analyze price movements of Mast Therapeutics Inc online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous MSTX quotes – including the latest bid at 42.08 USD and ask at 42.66 USD – and get all the necessary information for adding Mast Therapeutics Inc to your investment portfolio.

With R StocksTrader, you can invest in Mast Therapeutics Inc and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Mast Therapeutics Inc, and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of MSTX does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Mast Therapeutics Inc (MSTX).

You can trade Mast Therapeutics Inc (MSTX) on the R StocksTrader platform.

You can trade online Mast Therapeutics Inc (MSTX) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts